Paul Silber is a founding principal at Blu Venture Investors. He launched and grew In Vitro Technologies, Inc. for 15 years as President & CEO, and then led the successful sale of the company for $30M in 2006. He currently is a Board Director or Advisor to Encore Path, Inc., PA & Associates, Inc, Evergreen Advisors LLC, PathSensors, Inc., and The Biotechnical Institute of Maryland, and the chair of the Greater Baltimore Technology Council’s Biotech Roundtable. Paul has a Ph.D. in Toxicology, and 5 patents. He has a proven track record of growing a successful B2B technology company from inception to sale, focusing on innovation, execution, and creation of a valuable brand. He is also an investor in several companies including: Pathsensors, Oculis Labs, Straighterline, Encore Path, LiveLook and Kanasao.